Literature DB >> 14758167

Abnormal permeability of inner and outer mitochondrial membranes contributes independently to mitochondrial dysfunction in the liver during acute endotoxemia.

Elliott D Crouser1, Mark W Julian, Jennifer E Huff, Mandar S Joshi, John A Bauer, Martha E Gadd, Mark D Wewers, Douglas R Pfeiffer.   

Abstract

OBJECTIVE: This study was designed to determine the role played by the mitochondrial permeability transition in the pathogenesis of mitochondrial damage and dysfunction in a representative systemic organ during the acute phase of endotoxemia.
DESIGN: A well-established, normotensive feline model was employed to determine whether pretreatment with cyclosporine A, a potent inhibitor of the mitochondrial permeability transition, normalizes mitochondrial ultrastructural injury and dysfunction in the liver during acute endotoxemia.
SETTING: The Ohio State University Medical Center research laboratory.
SUBJECTS: Random source, adult, male conditioned cats.
INTERVENTIONS: Hemodynamic resuscitation and maintenance of acid-base balance and tissue oxygen availability were provided, as needed, to minimize the potentially confounding effects of tissue hypoxia and/or acidosis on the experimental results. Treatment groups received isotonic saline vehicle (control; n = 6), lipopolysaccharide (3.0 mg/kg, intravenously; n = 8), or cyclosporine A (6.0 mg/kg, intravenously; n = 6) or tacrolimus (FK506, 0.1 mg/kg, intravenously; n = 4) followed in 30 mins by lipopolysaccharide (3.0 mg/kg, intravenously). Liver samples were obtained 4 hrs posttreatment, and mitochondrial ultrastructure, function, and cytochrome c, Bax, and ceramide contents were assessed.
MEASUREMENTS AND MAIN RESULTS: As expected, significant mitochondrial injury was apparent in the liver 4 hrs after lipopolysaccharide treatment, despite maintenance of regional tissue oxygen availability. Namely, mitochondria demonstrated high-amplitude swelling and exhibited altered respiratory function. Cyclosporine A pretreatment attenuated lipopolysaccharide-induced mitochondrial ultrastructural abnormalities and normalized mitochondrial respiratory control, reflecting protection against inner mitochondrial membrane damage. However, an abnormal permeability of outer mitochondrial membranes to cytochrome c was observed in all lipopolysaccharide-treated groups and was associated with increased mitochondrial concentrations of Bax and ceramide.
CONCLUSIONS: These studies confirm that liver mitochondria are early targets of injury during endotoxemia and that inner and outer mitochondrial membrane damage occurs through different mechanisms. Inner mitochondrial membrane damage appears to relate to the mitochondrial permeability transition, whereas outer mitochondrial membrane damage can occur independent of the mitochondrial permeability transition. Preliminary evidence suggests that Bax may participate in lipopolysaccharide-induced outer mitochondrial membrane damage, but further investigations are needed to confirm this.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14758167     DOI: 10.1097/01.CCM.0000109449.99160.81

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  26 in total

1.  Hepatic oxidative injury: role of mitochondrial dysfunction in necrotizing enterocolitis.

Authors:  Edoardo Bindi; Mashriq Alganabi; George Biouss; Jia Liu; Bo Li; Hiromu Miyake; Rossella Angotti; Agostino Pierro
Journal:  Pediatr Surg Int       Date:  2021-02-06       Impact factor: 1.827

2.  Role of mitochondrial oxidants in an in vitro model of sepsis-induced renal injury.

Authors:  Elina Pathak; Lee Ann MacMillan-Crow; Philip R Mayeux
Journal:  J Pharmacol Exp Ther       Date:  2011-10-19       Impact factor: 4.030

3.  Endotoxemia impairs heart mitochondrial function by decreasing electron transfer, ATP synthesis and ATP content without affecting membrane potential.

Authors:  Virginia Vanasco; Natalia D Magnani; María Cecilia Cimolai; Laura B Valdez; Pablo Evelson; Alberto Boveris; Silvia Alvarez
Journal:  J Bioenerg Biomembr       Date:  2012-03-18       Impact factor: 2.945

Review 4.  Mitochondrial biogenesis: regulation by endogenous gases during inflammation and organ stress.

Authors:  Hagir B Suliman; Claude A Piantadosi
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

5.  Peritoneal inflammation in pigs is associated with early mitochondrial dysfunction in liver and kidney.

Authors:  Andrey V Kozlov; Martijn van Griensven; Susanne Haindl; Ingeborg Kehrer; J Catharina Duvigneau; Romana T Hartl; Thomas Ebel; Mohammad Jafarmadar; Enrico Calzia; Erich Gnaiger; Heinz Redl; Peter Radermacher; Soheyl Bahrami
Journal:  Inflammation       Date:  2010-10       Impact factor: 4.092

6.  Calcineurin regulates myocardial function during acute endotoxemia.

Authors:  Mandar S Joshi; Mark W Julian; Jennifer E Huff; John A Bauer; Yong Xia; Elliott D Crouser
Journal:  Am J Respir Crit Care Med       Date:  2006-01-19       Impact factor: 21.405

7.  Alterations in inflammatory mediators, oxidative stress parameters and energetic metabolism in the brain of sepsis survivor rats.

Authors:  Clarissa M Comim; Omar J Cassol; Larissa S Constantino; Francine Felisberto; Fabricia Petronilho; Gislaine T Rezin; Giselli Scaini; Juliana F Daufenbach; Emilio L Streck; João Quevedo; Felipe Dal-Pizzol
Journal:  Neurochem Res       Date:  2010-11-25       Impact factor: 3.996

Review 8.  Sepsis: links between pathogen sensing and organ damage.

Authors:  Elliott Crouser; Matthew Exline; Daren Knoell; Mark D Wewers
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 9.  Mitochondrial mechanisms of sepsis-induced organ failure.

Authors:  Matthew C Exline; Elliot D Crouser
Journal:  Front Biosci       Date:  2008-05-01

10.  Simvastatin and a Plant Galactolipid Protect Animals from Septic Shock by Regulating Oxylipin Mediator Dynamics through the MAPK-cPLA2 Signaling Pathway.

Authors:  Maria Karmella Apaya; Chih-Yu Lin; Ching-Yi Chiou; Chung-Chih Yang; Chen-Yun Ting; Lie-Fen Shyur
Journal:  Mol Med       Date:  2016-03-31       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.